Informative Perspective on the Artificial Pancreas
March 20, 2012 | Terry Sharrer
With more than 20 companies-including Medtronic, Johnson & Johnson, Mayo Clinic, and Insulet-having investigational device exemptions from the FDA, and pursing development of the “artificial pancreas,” it might be worth rereading this 2010 piece about strategies, performance, and barriers in a specific case. MORE